Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Jon Sussex, Yan Feng, Jorge Mestre-Ferrandiz, Michele Pistollato, Marco Hafner, Peter Burridge, Jonathan Grant

ABSTRACT

BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK. METHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements. RESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional £1 of public research expenditure is associated with an additional £0.83-£1.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%. CONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally. More... »

PAGES

32

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z

DOI

http://dx.doi.org/10.1186/s12916-016-0564-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011671285

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26908129


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomedical Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Charities", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Financial Management", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Government", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Health Expenditures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Econometric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Private Sector", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Public Sector", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "RAND Europe, Cambridge, UK", 
            "Formerly, Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sussex", 
        "givenName": "Jon", 
        "id": "sg:person.01351514340.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351514340.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feng", 
        "givenName": "Yan", 
        "id": "sg:person.0723015016.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723015016.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mestre-Ferrandiz", 
        "givenName": "Jorge", 
        "id": "sg:person.01351556637.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351556637.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Office Of Health Economics", 
          "id": "https://www.grid.ac/institutes/grid.482825.1", 
          "name": [
            "Formerly, Office of Health Economics, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pistollato", 
        "givenName": "Michele", 
        "id": "sg:person.0640155570.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640155570.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "RAND Europe", 
          "id": "https://www.grid.ac/institutes/grid.425785.9", 
          "name": [
            "RAND Europe, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hafner", 
        "givenName": "Marco", 
        "id": "sg:person.0756124517.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756124517.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of York", 
          "id": "https://www.grid.ac/institutes/grid.5685.e", 
          "name": [
            "Department of Economics, University of York, Heslington, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burridge", 
        "givenName": "Peter", 
        "id": "sg:person.07433773763.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07433773763.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Policy Institute at King\u2019s, King\u2019s College London, Strand Campus, WC2R 2LS, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grant", 
        "givenName": "Jonathan", 
        "id": "sg:person.01055471415.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1214/aos/1176346801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005460302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1467-9892.1984.tb00381.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006526701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1741-7015-12-99", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006565540", 
          "https://doi.org/10.1186/1741-7015-12-99"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0165-1765(97)00214-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006898116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-007-0059-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008662835", 
          "https://doi.org/10.1007/s00191-007-0059-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-007-0059-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008662835", 
          "https://doi.org/10.1007/s00191-007-0059-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266466600012421", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011322255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/amiajnl-2011-000213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031293266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031830107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1465-7295.1995.tb01847.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031830107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1467-6451.00067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042131484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-4076(95)01753-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051002956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/508314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058786261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/ipe.1.25056140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058907717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/icc/10.4.975", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059654576"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1162/0033553041502144", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063348973"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/1913236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069640597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074965672", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-017-0524-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091048368", 
          "https://doi.org/10.1007/s00191-017-0524-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00191-017-0524-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091048368", 
          "https://doi.org/10.1007/s00191-017-0524-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/cbo9780511492327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098680657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/0198774508.001.0001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1098730911"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK.\nMETHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements.\nRESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional \u00a31 of public research expenditure is associated with an additional \u00a30.83-\u00a31.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%.\nCONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12916-016-0564-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3560719", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3957548", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032885", 
        "issn": [
          "1741-7015"
        ], 
        "name": "BMC Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom", 
    "pagination": "32", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "379baa3a7fe38d157f494cfe7b82668269bc51191479f7b8de2366dea5cf901b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26908129"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190723"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12916-016-0564-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011671285"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12916-016-0564-z", 
      "https://app.dimensions.ai/details/publication/pub.1011671285"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12916-016-0564-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12916-016-0564-z'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      60 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12916-016-0564-z schema:about N0eb5d03dc3eb4b8bbb090887cce2c9f4
2 N3c67d66293a24c5691b2504200a9657f
3 N46afc57584bb415cbdfcdb367be203bf
4 N8b1003af74234835958dba6c9a9b547a
5 N92df6f95d2524392b5073eaa88c23a74
6 N97d0559cf6a24f33acc5ba97ce246b99
7 N9877c0cc3dd546aa8d973af72328e391
8 Na0f54c4a9ed74128bd5dbb667b1aa1ac
9 Nb4d9b84349834795a294747ce716302c
10 Nbf3f5ecf3cd344b1b63fd484d15171ca
11 Nd25f2e11b82b4f1fb86b7a979f4d8d4d
12 Nec7d8b6cdf2c43e482a9ba9f5f36ffe0
13 anzsrc-for:14
14 anzsrc-for:1402
15 schema:author Ne2bce7c2e5ed4c59976be724cab41188
16 schema:citation sg:pub.10.1007/s00191-007-0059-3
17 sg:pub.10.1007/s00191-017-0524-6
18 sg:pub.10.1186/1741-7015-12-99
19 https://app.dimensions.ai/details/publication/pub.1074965672
20 https://doi.org/10.1016/0304-4076(95)01753-4
21 https://doi.org/10.1016/s0165-1765(97)00214-0
22 https://doi.org/10.1017/cbo9780511492327
23 https://doi.org/10.1017/s0266466600012421
24 https://doi.org/10.1086/508314
25 https://doi.org/10.1086/ipe.1.25056140
26 https://doi.org/10.1093/0198774508.001.0001
27 https://doi.org/10.1093/icc/10.4.975
28 https://doi.org/10.1111/1467-6451.00067
29 https://doi.org/10.1111/j.1465-7295.1995.tb01847.x
30 https://doi.org/10.1111/j.1467-9892.1984.tb00381.x
31 https://doi.org/10.1136/amiajnl-2011-000213
32 https://doi.org/10.1162/0033553041502144
33 https://doi.org/10.1214/aos/1176346801
34 https://doi.org/10.2307/1913236
35 schema:datePublished 2016-12
36 schema:datePublishedReg 2016-12-01
37 schema:description BACKGROUND: Government- and charity-funded medical research and private sector research and development (R&D) are widely held to be complements. The only attempts to measure this complementarity so far have used data from the United States of America and are inevitably increasingly out of date. This study estimates the magnitude of the effect of government and charity biomedical and health research expenditure in the United Kingdom (UK), separately and in total, on subsequent private pharmaceutical sector R&D expenditure in the UK. METHODS: The results for this study are obtained by fitting an econometric vector error correction model (VECM) to time series for biomedical and health R&D expenditure in the UK for ten disease areas (including 'other') for the government, charity and private sectors. The VECM model describes the relationship between public (i.e. government and charities combined) sector expenditure, private sector expenditure and global pharmaceutical sales as a combination of a long-term equilibrium and short-term movements. RESULTS: There is a statistically significant complementary relationship between public biomedical and health research expenditure and private pharmaceutical R&D expenditure. A 1% increase in public sector expenditure is associated in the best-fit model with a 0.81% increase in private sector expenditure. Sensitivity analysis produces a similar and statistically significant result with a slightly smaller positive elasticity of 0.68. Overall, every additional £1 of public research expenditure is associated with an additional £0.83-£1.07 of private sector R&D spend in the UK; 44% of that additional private sector expenditure occurs within 1 year, with the remainder accumulating over decades. This spillover effect implies a real annual rate of return (in terms of economic impact) to public biomedical and health research in the UK of 15-18%. When combined with previous estimates of the health gain that results from public medical research in cancer and cardiovascular disease, the total rate of return would be around 24-28%. CONCLUSION: Overall, this suggests that government and charity funded research in the UK crowds in additional private sector R&D in the UK. The implied historical returns from UK government and charity funded investment in medical research in the UK compare favourably with the rates of return achieved on investments in the rest of the UK economy and are greatly in excess of the 3.5% real annual rate of return required by the UK government to public investments generally.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree true
41 schema:isPartOf N54fc66d9f84a4abd9657dfd04e50ce2c
42 N9340d8a01a314de881507f41847c10ed
43 sg:journal.1032885
44 schema:name Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom
45 schema:pagination 32
46 schema:productId N376d01cae2094bca943fc5e617d58966
47 N7b80f39011b24af49e55ebc910babc7a
48 N95e798fa61e44eaeb469de61c9e37515
49 Nd964495415004ecbab2d41e4902590c4
50 Nf256baa60c3d41268cd5341ea2eee981
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011671285
52 https://doi.org/10.1186/s12916-016-0564-z
53 schema:sdDatePublished 2019-04-10T19:15
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N44b5fa37fea74062b5d0acb334627ba6
56 schema:url http://link.springer.com/10.1186%2Fs12916-016-0564-z
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N0eb5d03dc3eb4b8bbb090887cce2c9f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Humans
62 rdf:type schema:DefinedTerm
63 N1a9150414d8842d8a2c163f5388ef37a rdf:first sg:person.07433773763.16
64 rdf:rest N3ceeaefbf03f4cbfb2fc74d7054f0669
65 N376d01cae2094bca943fc5e617d58966 schema:name nlm_unique_id
66 schema:value 101190723
67 rdf:type schema:PropertyValue
68 N3c67d66293a24c5691b2504200a9657f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Neoplasms
70 rdf:type schema:DefinedTerm
71 N3ceeaefbf03f4cbfb2fc74d7054f0669 rdf:first sg:person.01055471415.15
72 rdf:rest rdf:nil
73 N44b5fa37fea74062b5d0acb334627ba6 schema:name Springer Nature - SN SciGraph project
74 rdf:type schema:Organization
75 N46afc57584bb415cbdfcdb367be203bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Private Sector
77 rdf:type schema:DefinedTerm
78 N54fc66d9f84a4abd9657dfd04e50ce2c schema:issueNumber 1
79 rdf:type schema:PublicationIssue
80 N583fcdbd92794fd0920994271c9fad70 rdf:first sg:person.0640155570.04
81 rdf:rest N886316275bc2416a942fe2461d71fc64
82 N7b80f39011b24af49e55ebc910babc7a schema:name readcube_id
83 schema:value 379baa3a7fe38d157f494cfe7b82668269bc51191479f7b8de2366dea5cf901b
84 rdf:type schema:PropertyValue
85 N886316275bc2416a942fe2461d71fc64 rdf:first sg:person.0756124517.33
86 rdf:rest N1a9150414d8842d8a2c163f5388ef37a
87 N8b1003af74234835958dba6c9a9b547a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Financial Management
89 rdf:type schema:DefinedTerm
90 N92df6f95d2524392b5073eaa88c23a74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Charities
92 rdf:type schema:DefinedTerm
93 N9340d8a01a314de881507f41847c10ed schema:volumeNumber 14
94 rdf:type schema:PublicationVolume
95 N95e798fa61e44eaeb469de61c9e37515 schema:name pubmed_id
96 schema:value 26908129
97 rdf:type schema:PropertyValue
98 N97d0559cf6a24f33acc5ba97ce246b99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Biomedical Research
100 rdf:type schema:DefinedTerm
101 N9877c0cc3dd546aa8d973af72328e391 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Models, Econometric
103 rdf:type schema:DefinedTerm
104 Na0f54c4a9ed74128bd5dbb667b1aa1ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name United Kingdom
106 rdf:type schema:DefinedTerm
107 Nb4d9b84349834795a294747ce716302c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Health Expenditures
109 rdf:type schema:DefinedTerm
110 Nbf3f5ecf3cd344b1b63fd484d15171ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Research
112 rdf:type schema:DefinedTerm
113 Nd25f2e11b82b4f1fb86b7a979f4d8d4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Government
115 rdf:type schema:DefinedTerm
116 Nd964495415004ecbab2d41e4902590c4 schema:name dimensions_id
117 schema:value pub.1011671285
118 rdf:type schema:PropertyValue
119 Nda52b16a17be47a6b051aefa5218b9d7 rdf:first sg:person.0723015016.37
120 rdf:rest Nf82e4991165e4bffb426fe3ea5e1facf
121 Ne2bce7c2e5ed4c59976be724cab41188 rdf:first sg:person.01351514340.11
122 rdf:rest Nda52b16a17be47a6b051aefa5218b9d7
123 Nec7d8b6cdf2c43e482a9ba9f5f36ffe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Public Sector
125 rdf:type schema:DefinedTerm
126 Nf256baa60c3d41268cd5341ea2eee981 schema:name doi
127 schema:value 10.1186/s12916-016-0564-z
128 rdf:type schema:PropertyValue
129 Nf82e4991165e4bffb426fe3ea5e1facf rdf:first sg:person.01351556637.67
130 rdf:rest N583fcdbd92794fd0920994271c9fad70
131 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
132 schema:name Economics
133 rdf:type schema:DefinedTerm
134 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
135 schema:name Applied Economics
136 rdf:type schema:DefinedTerm
137 sg:grant.3560719 http://pending.schema.org/fundedItem sg:pub.10.1186/s12916-016-0564-z
138 rdf:type schema:MonetaryGrant
139 sg:grant.3957548 http://pending.schema.org/fundedItem sg:pub.10.1186/s12916-016-0564-z
140 rdf:type schema:MonetaryGrant
141 sg:journal.1032885 schema:issn 1741-7015
142 schema:name BMC Medicine
143 rdf:type schema:Periodical
144 sg:person.01055471415.15 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
145 schema:familyName Grant
146 schema:givenName Jonathan
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055471415.15
148 rdf:type schema:Person
149 sg:person.01351514340.11 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
150 schema:familyName Sussex
151 schema:givenName Jon
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351514340.11
153 rdf:type schema:Person
154 sg:person.01351556637.67 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
155 schema:familyName Mestre-Ferrandiz
156 schema:givenName Jorge
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351556637.67
158 rdf:type schema:Person
159 sg:person.0640155570.04 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
160 schema:familyName Pistollato
161 schema:givenName Michele
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640155570.04
163 rdf:type schema:Person
164 sg:person.0723015016.37 schema:affiliation https://www.grid.ac/institutes/grid.482825.1
165 schema:familyName Feng
166 schema:givenName Yan
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723015016.37
168 rdf:type schema:Person
169 sg:person.07433773763.16 schema:affiliation https://www.grid.ac/institutes/grid.5685.e
170 schema:familyName Burridge
171 schema:givenName Peter
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07433773763.16
173 rdf:type schema:Person
174 sg:person.0756124517.33 schema:affiliation https://www.grid.ac/institutes/grid.425785.9
175 schema:familyName Hafner
176 schema:givenName Marco
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756124517.33
178 rdf:type schema:Person
179 sg:pub.10.1007/s00191-007-0059-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008662835
180 https://doi.org/10.1007/s00191-007-0059-3
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/s00191-017-0524-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091048368
183 https://doi.org/10.1007/s00191-017-0524-6
184 rdf:type schema:CreativeWork
185 sg:pub.10.1186/1741-7015-12-99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006565540
186 https://doi.org/10.1186/1741-7015-12-99
187 rdf:type schema:CreativeWork
188 https://app.dimensions.ai/details/publication/pub.1074965672 schema:CreativeWork
189 https://doi.org/10.1016/0304-4076(95)01753-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051002956
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s0165-1765(97)00214-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006898116
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1017/cbo9780511492327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098680657
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1017/s0266466600012421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011322255
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1086/508314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058786261
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1086/ipe.1.25056140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058907717
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1093/0198774508.001.0001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1098730911
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1093/icc/10.4.975 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059654576
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1111/1467-6451.00067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042131484
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1111/j.1465-7295.1995.tb01847.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031830107
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1111/j.1467-9892.1984.tb00381.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006526701
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1136/amiajnl-2011-000213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031293266
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1162/0033553041502144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063348973
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1214/aos/1176346801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005460302
216 rdf:type schema:CreativeWork
217 https://doi.org/10.2307/1913236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069640597
218 rdf:type schema:CreativeWork
219 https://www.grid.ac/institutes/grid.13097.3c schema:alternateName King's College London
220 schema:name Policy Institute at King’s, King’s College London, Strand Campus, WC2R 2LS, London, UK
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.425785.9 schema:alternateName RAND Europe
223 schema:name RAND Europe, Cambridge, UK
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.482825.1 schema:alternateName Office Of Health Economics
226 schema:name Formerly, Office of Health Economics, London, UK
227 Office of Health Economics, London, UK
228 RAND Europe, Cambridge, UK
229 rdf:type schema:Organization
230 https://www.grid.ac/institutes/grid.5685.e schema:alternateName University of York
231 schema:name Department of Economics, University of York, Heslington, UK
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...